AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.63−0.57 (-3.52%)
Close on Nov 13, 2026Market cap $483.39MP/E –Yield –
AVITA Medical cash
Cash and short-term investments held at the end of each period.
AVITA Medical's cash was $10.50M at Sep 30, 2026. For fiscal 2025 it was $18.20M, down 49.3% from the year before. The highest annual figure on record is $110.75M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.20M | -49.3% |
| FY2024 | Dec 31, 2024 | $35.90M | -59.7% |
| FY2023 | Dec 31, 2023 | $89.06M | -19.6% |
| FY2021 | Jun 30, 2021 | $110.75M | +50.0% |
| FY2020 | Jun 30, 2020 | $73.84M | +262.4% |
| FY2019 | Jun 30, 2019 | $20.37M | +85.5% |
| FY2018 | Jun 30, 2018 | $10.99M | +277.0% |
| FY2017 | Jun 30, 2017 | $2.91M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $10.50M | -54.9% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $11.10M | -29.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $14.30M | -44.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $18.20M | -49.3% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $23.30M | -65.0% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $15.70M | -77.6% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $25.80M | -64.2% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $35.90M | -59.7% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $66.67M | +10.9% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $70.20M | +6.3% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $72.13M | -1.8% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $89.06M | -19.6% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $60.12M | -47.8% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $66.05M | +10.1% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $73.45M | +11.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $110.75M | +50.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $115.08M | +44.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $59.97M | -31.4% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $65.95M | +331.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $73.84M | +262.4% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $79.76M | +626.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $87.46M | +2901.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $15.30M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $20.37M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $10.99M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $2.91M | – |
See a number that looks wrong?